Medicare Drug Plan Premiums Set to Rise 50% in 2027
Medicare prescription drug costs face a steep 50% increase in 2027, making active open enrollment participation critical for beneficiaries.
Medicare prescription drug plan costs are projected to surge roughly 50% in 2027, a sharp increase that could catch beneficiaries off guard if they fail to review their coverage options during open enrollment, according to a report from MarketWatch.
The increase underscores the financial stakes involved in annual Medicare plan selection. Beneficiaries who do nothing — allowing their current plan to auto-renew — risk absorbing higher out-of-pocket costs that could have been avoided by switching to a more competitive plan during the enrollment window.
Read more Free Retirement Dinner Seminars Often Mask Annuity Sales Pitches →
Open enrollment periods are specifically designed to give Medicare participants the opportunity to compare plans, assess premium changes, and make adjustments that reflect their current health and financial needs. Skipping this process, particularly heading into a year with outsized cost increases, amplifies exposure to unnecessary expenses.
Financial advisers and Medicare counselors broadly recommend that enrollees treat each open enrollment season as a fresh evaluation, rather than a passive rollover. Plan formularies, covered medications, and premium structures can shift significantly year over year, meaning last year's best option may no longer be the most cost-effective choice.
With a 50% cost jump on the horizon for 2027, the urgency to engage with open enrollment options is especially acute. Beneficiaries are encouraged to use Medicare's official plan-comparison tools and consult licensed counselors to identify coverage that best fits their medication needs and budget. Continue reading at MarketWatch.com
